Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q2

3750.TEDINET S100S7YU
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥863m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥354m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥381m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥424m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥437m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥419m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax−¥539m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥443m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥561m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥443m2023-04-01 → 2023-09-30Cons.Profit loss
Net income−¥561m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥13.6bnat 2023-09-30Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥11.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥658mat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥208mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥673mat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥561mat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥702mat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥367m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥40m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥20m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥283m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥94m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥94m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥294m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥67m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.652023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.592023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.862022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.662022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio14.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio20.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥87m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-09-30−¥285m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-09-30¥17m
—segment totalrevenue2023-04-01 → 2023-09-30¥863m
—segment totalrevenue external2023-04-01 → 2023-09-30¥863m
—segment totalsegment profit2023-04-01 → 2023-09-30−¥267m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥74m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-09-30−¥119m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-09-30−¥188m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥307m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration－JPY
Loss on sale of investments in capital of subsidiaries and associates elPrior1YTDDuration107628000JPY
Loss on sale of investments in capital of subsidiaries and associates elCurrentYTDDuration－JPY
Impairment loss elPrior1YTDDuration6172000JPY
Impairment loss elCurrentYTDDuration－JPY
Other elPrior1YTDDuration619000JPY
Other elCurrentYTDDuration274000JPY
Extraordinary lossPrior1YTDDuration114419000JPY
Extraordinary lossCurrentYTDDuration274000JPY
Income before dividends distribution from silent partnership income taxesPrior1YTDDuration-551790000JPY
Income before dividends distribution from silent partnership income taxesCurrentYTDDuration-423803000JPY
Dividends distribution from silent partnershipPrior1YTDDuration-12785000JPY
Dividends distribution from silent partnershipCurrentYTDDuration-4521000JPY
Income before income taxesPrior1YTDDuration-539005000JPY
Income before income taxesCurrentYTDDuration-419281000JPY
Income taxes currentPrior1YTDDuration960000JPY
Income taxes currentCurrentYTDDuration983000JPY
Income taxes deferredPrior1YTDDuration21300000JPY
Income taxes deferredCurrentYTDDuration22668000JPY
Income taxesPrior1YTDDuration22260000JPY
Income taxesCurrentYTDDuration23651000JPY
Profit lossPrior1YTDDuration-561266000JPY
Profit lossCurrentYTDDuration-442932000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration15000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration402000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-561281000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-443334000JPY
Profit lossPrior1YTDDuration-561266000JPY
Profit lossCurrentYTDDuration-442932000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-17000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration77000JPY
Other comprehensive incomePrior1YTDDuration-17000JPY
Other comprehensive incomeCurrentYTDDuration77000JPY
Comprehensive incomePrior1YTDDuration-561283000JPY
Comprehensive incomeCurrentYTDDuration-442854000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-561299000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-443256000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration15000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration402000JPY
Income before income taxesPrior1YTDDuration-539005000JPY
Income before income taxesCurrentYTDDuration-419281000JPY
Depreciation and amortization ope cfPrior1YTDDuration145803000JPY
Depreciation and amortization ope cfCurrentYTDDuration104837000JPY
Amortization of goodwill ope cfPrior1YTDDuration22966000JPY
Amortization of goodwill ope cfCurrentYTDDuration22966000JPY
Loss on sale of investments in capital of subsidiaries and associates ope cfPrior1YTDDuration107628000JPY
Loss on sale of investments in capital of subsidiaries and associates ope cfCurrentYTDDuration－JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration10029000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration3248000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass